V. Ratziu
发表论文 650 篇 · 总被引 59884 次 · h-index 108
代表论文
- A multisociety Delphi consensus statement on new fatty liver disease nomenclature (2023 · Hepatology · 被引 2378)
- Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial (2023 · The Lancet Gastroenterology and Hepatology · 被引 356)
- Clinical Trial Landscape in NASH. (2023 · Clinical Gastroenterology and Hepatology · 被引 93)
- Confirmatory biomarker diagnostic studies are not needed when transitioning from NAFLD to MASLD. (2023 · Journal of Hepatology · 被引 90)
- Design of the phase 3 MAESTRO clinical program to evaluate resmetirom for the treatment of nonalcoholic steatohepatitis (2023 · Alimentary Pharmacology and Therapeutics · 被引 77)
- Evaluation of PXL065 - Deuterium-Stabilized (R)-Pioglitazone in NASH Patients: a Phase 2 randomized placebo-controlled trial (DESTINY-1). (2023 · Journal of Hepatology · 被引 65)